BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19331595)

  • 41. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
    Abut E; Yaşar B; Güveli H; Bölükbaş C; Bölükbaş FF; Dalay AR; Kurdaş OO
    Scand J Gastroenterol; 2010 Jun; 45(6):677-83. PubMed ID: 20334478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erdosteine enhances mucociliary clearance in rats with and without airway inflammation.
    Hosoe H; Kaise T; Ohmori K
    J Pharmacol Toxicol Methods; 1998 Oct; 40(3):165-71. PubMed ID: 10334633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells.
    Demiralay R; Gürsan N; Erdem H
    Toxicology; 2006 Feb; 219(1-3):197-207. PubMed ID: 16377052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
    Selcoki Y; Uz E; Bayrak R; Sahin S; Kaya A; Uz B; Karanfil A; Ozkara A; Akcay A
    Toxicology; 2007 Sep; 239(1-2):53-9. PubMed ID: 17689165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
    Tse HN; Tseng CZ
    Int J Chron Obstruct Pulmon Dis; 2014; 9():825-36. PubMed ID: 25125976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.
    Fraňová S; Kazimierová I; Pappová L; Molitorisová M; Jošková M; Šutovská M
    Pulm Pharmacol Ther; 2019 Feb; 54():60-67. PubMed ID: 30502381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease.
    Moretti M
    Expert Rev Respir Med; 2007 Dec; 1(3):307-16. PubMed ID: 20477170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents.
    Poole PJ; Black PN
    Am J Respir Med; 2003; 2(5):367-70. PubMed ID: 14719989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antioxidant effect of erdosteine and lipoic acid in ovarian ischemia-reperfusion injury.
    Dokuyucu R; Karateke A; Gokce H; Kurt RK; Ozcan O; Ozturk S; Tas ZA; Karateke F; Duru M
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():23-7. PubMed ID: 25461347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial.
    Chang AB; Yerkovich ST; Baines KJ; Burr L; Champion A; Chatfield MD; Eg KP; Goyal V; Marsh RL; McCallum GB; McElrea M; McPhail S; Morgan LC; Morris PS; Nathan AM; O'Farrell H; Sanchez MO; Parsons M; Schultz A; Torzillo PJ; West NP; Versteegh L; Marchant JM; Grimwood K
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38719503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of erdosteine, a second generation mucolytic agent, in children with acute rhinosinusitis: a randomized, placebo controlled, double-blinded clinical study.
    Unuvar E; Tamay Z; Yildiz I; Toprak S; Kilic A; Aydin S; Kilic G; Guler N; Oguz F; Sidal M
    Acta Paediatr; 2010 Apr; 99(4):585-9. PubMed ID: 20055782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of erdosteine against hypochlorous acid-induced acute lung injury and lipopolysaccharide-induced neutrophilic lung inflammation in mice.
    Hayashi K; Hosoe H; Kaise T; Ohmori K
    J Pharm Pharmacol; 2000 Nov; 52(11):1411-6. PubMed ID: 11186250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction.
    Sener G; Sehirli AO; Toklu HZ; Yuksel M; Ercan F; Gedik N
    Pediatr Surg Int; 2007 Mar; 23(3):233-41. PubMed ID: 17216233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin].
    Erden ES; Kirkil G; Deveci F; Ilhan N; Cobanoğlu B; Turgut T; Muz MH
    Tuberk Toraks; 2008; 56(2):127-38. PubMed ID: 18701972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities.
    Sener G; Aksoy H; Sehirli O; Yüksel M; Aral C; Gedik N; Cetinel S; Yeğen BC
    Dig Dis Sci; 2007 Sep; 52(9):2122-32. PubMed ID: 17431768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.
    Zheng JP; Kang J; Huang SG; Chen P; Yao WZ; Yang L; Bai CX; Wang CZ; Wang C; Chen BY; Shi Y; Liu CT; Chen P; Li Q; Wang ZS; Huang YJ; Luo ZY; Chen FP; Yuan JZ; Yuan BT; Qian HP; Zhi RC; Zhong NS
    Lancet; 2008 Jun; 371(9629):2013-8. PubMed ID: 18555912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of mucolytic agents and macrolides in the treatment of COPD].
    Yamaya M
    Nihon Rinsho; 2016 May; 74(5):833-8. PubMed ID: 27254955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin].
    Karapolat S
    Tuberk Toraks; 2009; 57(2):244-5; author reply 245-6. PubMed ID: 19714520
    [No Abstract]   [Full Text] [Related]  

  • 59. Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics.
    Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
    Trends Pharmacol Sci; 2019 Jul; 40(7):452-463. PubMed ID: 31147200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of erdosteine on cyclosporin-A-induced nephrotoxicity.
    Tutanc M; Arica V; Yılmaz N; Nacar A; Zararsiz I; Basarslan F; Tutanc OD; Nacar E
    Hum Exp Toxicol; 2012 Jun; 31(6):565-73. PubMed ID: 21813577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.